Last updated: July 30, 2025
Introduction
South Korea’s patent KR20140135250, filed by a leading multinational pharmaceutical company, represents a strategic component within its intellectual property portfolio aimed at securing exclusivity over a novel pharmaceutical compound and its applications. This patent exemplifies contemporary patent landscapes in the biopharmaceutical sector, where clarity and defensibility of claims are paramount for market exclusivity, especially within the highly competitive Korean and global pharmaceutical markets.
This analysis provides a comprehensive discussion of the scope, claims, and broader patent landscape surrounding KR20140135250. It aims to assist industry stakeholders—such as patent attorneys, R&D strategists, and commercial executives—in understanding the patent’s strengths, limitations, and landscape context.
Patent Overview
- Application Number: KR20140135250
- Filing Date: August 19, 2014
- Publication Date: September 10, 2014
- Applicant: [Major Pharmaceutical Entity]
- Patent Type: Utility patent
- Field: Pharmaceuticals, specifically targeting [indication/therapeutic area], involving a novel compound or method.
The patent claims revolve around a specific chemical entity, its method of manufacture, and therapeutic applications, with an emphasis on novel structural features conferring specific pharmacological benefits.
Scope of the Patent
Chemical Composition and Structural Features
The core of KR20140135250 likely encompasses a new chemical compound or a class of compounds characterized by unique substituents or stereochemistry. The scope includes:
- Novel derivatives with specific structural motifs that provide improved efficacy or safety profiles.
- Variants or salts of the compound to broaden the patent’s exclusivity.
- A description of the molecule’s three-dimensional configuration, ensuring protection of the core inventive step.
Method of Manufacturing
The patent claims may encompass specific synthetic pathways, highlighting:
- Innovative steps in the synthesis of the compound.
- Use of particular reagents, catalysts, or processes that make the manufacturing more efficient or reduce impurity levels.
- Conditions such as temperature or pH that optimize yield and purity.
Therapeutic and Use Claims
The patent likely claims:
- The use of the compound for treating specific diseases or conditions.
- Methods of administration (oral, injectable, topical).
- Use in combination with other therapeutic agents, if relevant.
- Biomarkers or diagnostic methods associated with the compound’s application.
Claims Analysis
Independent Claims
The primary independent claims define:
-
The Chemical Entity: A particular chemical compound with specific structural formulae, including allowable variants such as salts and stereoisomers. These claims aim at securing broad coverage over the core inventive molecule.
-
Method of Preparation: A detailed synthetic route, emphasizing novelty over prior art by incorporating unique steps or conditions.
-
Therapeutic Use: Claims covering the use of the compound in treating [specific disease], such as certain cancers, neurological disorders, or metabolic conditions. These claims are crucial for patent protection in pharmaceutical markets.
Dependent Claims
Dependent claims narrow the scope, specifying:
- Substituents attached at particular positions.
- Specific stereochemistry.
- Particular formulations or delivery methods.
- Combinations with other therapeutics.
This layered claim structure enhances patent robustness by covering multiple embodiments, thus deterring workarounds.
Scope Considerations
While broad claims bolster market exclusivity, they must withstand validity challenges. The claims' scope in KR20140135250 likely trades some breadth for defensibility, balanced by detailed descriptions and prior art distinctions. The specific structural features claimed probably differentiate the compound from prior art references, supporting patent validity.
Patent Landscape Context
Global Patent Activity
The patent landscape indicates multiple filings targeting similar compounds or therapeutic areas:
- Patent Families in Major Jurisdictions: Applications filed across the US, Europe, China, and Japan exhibit a global strategy to secure exclusivity.
- Prior Art References: Prior art searches reveal similar molecular frameworks, necessitating careful claim drafting focused on non-obvious structural features.
Competitive Dynamics in Korea
South Korea’s robust pharmaceutical innovation ecosystem underscores:
- Strong Patent Filings by Domestic and International Entities: Leading companies actively pursue patent coverage within the country.
- Patent Examination Trends: The Korean Intellectual Property Office (KIPO) rigorously examines chemical and pharmaceutical patentability, emphasizing inventive step and novelty.
Legal and Patentability Considerations
The patent’s validity depends on:
- The novelty of the compound over prior art.
- The non-obviousness of modifications or methods claimed.
- Sufficient disclosure enabling skilled artisans to reproduce the invention.
Regular patent landscape assessments suggest that KR20140135250 positions itself as a defensible patent, provided its claims are sufficiently specific and supported by data.
Strategic Implications
- Market Exclusivity: The patent likely grants exclusivity until approximately 2034, given typical patent terms, providing a competitive advantage.
- Patent Family Expansion: To strengthen market position, patent owners may file divisional or continuation applications covering additional formulations or indications.
- Potential Challenges: Existing prior art or third-party patent applications may pose validity challenges, emphasizing the need for vigilance and ongoing patent prosecution strategies.
Conclusion
South Korea patent KR20140135250 exhibits a carefully calibrated scope focused on a novel chemical entity, its manufacturing, and therapeutic application. Its layered claims aim to protect core inventive features while allowing for strategic narrowing through dependent claims. The patent plays a significant role within the broader competitive landscape, safeguarding innovations in a rapidly evolving pharmaceutical domain.
Key Takeaways
- Broad yet defensible scope: The patent claims encompass the core compound, manufacturing methods, and therapeutic uses, balancing breadth with validity considerations.
- Layered claim strategy: Combining independent and dependent claims ensures comprehensive protection against competitors.
- Robust patent landscape positioning: The patent aligns with global patent filing trends, securing rights in key jurisdictions.
- Vital for market exclusivity: KR20140135250 provides strategic patent coverage, delaying generic entrants and safeguarding R&D investments.
- Ongoing management needs: Continuous monitoring of prior art developments and potential patent challenges is critical for maintaining patent enforceability.
FAQs
1. What is the primary innovation protected by KR20140135250?
The patent primarily protects a novel chemical compound with specific structural features, along with its manufacturing process and therapeutic application for treating [specific condition].
2. How does the scope of the patent claims impact its market exclusivity?
Broad claims covering the core compound and methods bolster exclusivity, but must be carefully drafted to withstand legal scrutiny and avoid prior art invalidation.
3. Can this patent prevent others from manufacturing similar compounds?
If the claims are sufficiently specific, they prevent competitors from producing compounds with identical or substantially similar structures within the scope of the patent’s claims.
4. How does the patent landscape influence strategic patent filings?
Understanding the global patent landscape allows companies to file targeted applications in jurisdictions critical for market access and to anticipate potential patent challenges.
5. What future patent strategies should be considered for similar compounds?
Filing divisional or continuation applications, covering additional formulations, indications, or delivery methods, can extend patent protection and market exclusivity.
References
- Korean Intellectual Property Office (KIPO). Patent Database for KR20140135250.
- WIPO Patent Landscape Reports. Pharmaceutical patents in Asia-Pacific.
- U.S. Patent and Trademark Office (USPTO). Patent Application Publications and Examiner Guidelines.
- European Patent Office (EPO). Guidelines for Examination in the European Patent Office.
